依达拉奉联合尤瑞克林治疗急性进展性脑梗死的临床观察

发布时间：2018-01-21 16:10

本文关键词： 脑梗死尤瑞克林　出处：《世界最新医学信息文摘》2016年65期 　论文类型：期刊论文

【摘要】：急性脑梗死是神经内科常见的危急重症疾病,具有起病急、进展迅速、致残率高、病死率高等特点,严重威胁着人们的生命健康。急性进展性脑梗死是指起病后6h后,由于引起梗死发生的原发病理过程仍继续进展,从而使经功能在一段时间内继续恶化的一种难治性脑梗死,其死亡率高于一般脑梗死[1]。急性进展性脑梗死目前国内外尚缺乏有效的治疗手段,是神经内科医师面临的难题之一。因此,积极寻找急性进展性脑梗死的新型治疗方法是近年来的研究热点。目前研究已证实,尤瑞克林能显著改善微循环,增加脑血流储备能力,改善神经功能缺损程度。
[Abstract]:Acute cerebral infarction is a common critical and severe disease in neurology department. It has the characteristics of acute onset, rapid progress, high disability rate and high mortality. Acute progressive cerebral infarction is 6 hours after onset of the disease, due to the occurrence of infarction due to the primary process still continues to progress. Thus, the mortality of refractory cerebral infarction, whose meridian function continues to deteriorate for a period of time, is higher than that of general cerebral infarction. [1. There is a lack of effective treatment for acute progressive cerebral infarction at home and abroad, which is one of the difficult problems faced by neurologists. Active search for a new treatment for acute progressive cerebral infarction has been a hot topic in recent years. At present, it has been confirmed that eurekline can significantly improve microcirculation and increase the capacity of cerebral blood flow reserve. To improve the degree of nerve function defect.
【作者单位】：黑龙江省佳木斯市大学附属第一医院;
【分类号】：R743.33
【正文快照】： 1 资料与方法 1.1 临床资料。选择2015年3月至2016年3月在佳木斯大学附属第一医院神经内科住院治疗的急性进展性脑梗死患者110例,诊断均符合2013年第四届全国脑血管病学术会议诊断标准和“中国脑血管病防治指南”诊断标准[2],既往史积分和伴发病积分按照“卒中患者临床神经

【参考文献】